Tests:Gentamicin: Difference between revisions

Tests:Gentamicin
No edit summary
Updated method Alinity
 
(3 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{| class="wikitable"
{| class="wikitable"
! colspan="2" |
! colspan="2" |
=== ''Overview'' ===
== Overview ==
|-
|-
|Department
|Department
Line 16: Line 16:


Garamycin   
Garamycin   
|-
|Availability
|Monday - Sunday, testing routinely available out of hours
|-
|-
|Turnaround Time
|Turnaround Time
Line 24: Line 27:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Specimen Requirements'' ===
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Serum
|Serum
Plasma
Plasma
|-
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
Line 39: Line 39:
|6 mL Li-Hep <span style="background:#3cb371"> Green-Top </span>   
|6 mL Li-Hep <span style="background:#3cb371"> Green-Top </span>   
|-
|-
|Pediatric Requirements   
|Unacceptable
|<span style="background:#99e6b3"> Li-Hep Microtainer </span>  
|Grossly haemolysed specimens
|-
|Specimen Transportation
|
|-
|Paediatric Requirements   
|<span style="background:#99e6b3"> Li-Hep Microtainer </span>
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Aliquot Requirements'' ===
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample  
|Plasma or Serum   
|Plasma or Serum   
|-
|Preferred Volume
|0.5 mL
|-
|-
|Minimum Volume
|Minimum Volume
|0.5 mL
|
|-
|-
|Aliquot Transportation
|Aliquot Transportation
Line 55: Line 64:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Clinical Information'' ===
== Clinical Information ==
|-
|-
|Reference Intervals
|Reference Intervals
Line 61: Line 70:
|-
|-
|Test Method
|Test Method
|Abbott Alinity Ci analyser using Abbott reagents.   
|Abbott Alinity c series analyser using Abbott reagents.   
|-
|-
|Advanced Notice
|Advanced Notice
Line 70: Line 79:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Comments'' ===
== Comments ==
|-
|-
| colspan="2" |State time of last dose and time of sampling on request  form.   
| colspan="2" |State time of last dose and time of sampling on request  form.   
Line 78: Line 87:
It is rarely necessary to routinely monitor aminoglycoside levels during the first 48 hours.   
It is rarely necessary to routinely monitor aminoglycoside levels during the first 48 hours.   
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}